Conclusions Telmisartan was equivalent to ramipril in patients with vascular disease or high-risk diabetes and was associated with less angioedema.

• 结论：替米沙坦与雷米普利对血管性疾病和高危糖尿病患者的治疗效果相同并且血管性水肿发生率较低。